Clinical Trials on Hypertension,Essential in Australia

Total 405 results

Medical University of Graz

Completed

Magnetic Resonance Imaging in the Diagnosis of Pulmonary Hypertension

Pulmonary Hypertension | Ventricular Function | MR Phase Contrast Velocity Imaging | Late Enhancement Patterns

Austria
Dr. Anton Hommer

Completed

An Open, Non-randomized Pilot Study on the Effect of Preservative Free Tafluprost (Saflutan® Augentropfen) in Patients With Ocular Hypertension or Primary Open Angle Glaucoma With an Uncontrolled Intraocular Pressure of 30 mmHg and More

Primary Open Angle Glaucoma | Ocular Hypertension

Austria
Medical University of Graz

Enrolling by invitation

Non-contrast Enhanced Cardiac Magnetic Resonance Imaging in the Diagnosis and Classification of Pulmonary Hypertension (CMR-PH)

Pulmonary Hypertension | Elevated Mean Pulmonary Arterial Pressure | Normal Mean Pulmonary Arterial Pressure

Austria
Actelion

Completed

BREATHE 5-OL: Tracleer (Bosentan) in Patients With Pulmonary Arterial Hypertension Related to Eisenmenger Physiology

Pulmonary Arterial Hypertension

Canada, United Kingdom, Italy, United States, Netherlands, Australia, Austria, Belgium, France, Germany, Spain
GlaxoSmithKline

Active, not recruiting

Extended Access of Momelotinib in Adults With Myelofibrosis

Neoplasms | Primary Myelofibrosis (PMF) | Post-polycythemia Vera Myelofibrosis (Post-PV MF) | Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)

United States, Hungary, Israel, Spain, Taiwan, France, Australia, Germany, Belgium, Canada, Singapore, Korea, Republic of, United Kingdom, Denmark, Austria, Romania, Italy, Bulgaria, Poland, Netherlands
Novartis Pharmaceuticals
Baker Heart and Diabetes Institute

Completed

Valsartan Intensified Primary Care Reduction of Blood Pressure Study (VIPER-BP)

Hypertension

United States, Australia
Bayer

Completed

EXPERT, EXPosurE Registry RiociguaT in Patients With Pulmonary Hypertension (EXPERT)

Hypertension, Pulmonary

Turkey, Austria, Czechia, Russian Federation, Slovakia, Switzerland, Italy, Germany, United Kingdom, France, Belgium, Canada, Colombia, Greece, Luxembourg, Netherlands, Spain, Taiwan, Denmark, Sweden, Argentina, Portugal, Saudi Arabia, Austral... and more
SciPharm SàRL

Completed

Efficacy and Tolerability of Subcutaneously Administered Treprostinil Sodium in Patients With Severe (Non-operable) Chronic Thromboembolic Pulmonary Hypertension (CTREPH) (CTREPH)

Non-operable Chronic Thromboembolic Pulmonary Hypertension

Austria, Poland, Czechia, Germany
Karl Landsteiner University of Health Sciences
University Hospital St. Pölten

Recruiting

hepatomiR cACLD Study

Portal Hypertension | Chronic Liver Disease | Chronic Liver Disease and Cirrhosis

Austria
CTI BioPharma

Terminated

Pacritinib Versus Best Available Therapy to Treat Patients With Myelofibrosis and Thrombocytopenia (PAC326)

Primary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia Myelofibrosis

United States, Canada, France, United Kingdom, Australia, Belgium, Germany, New Zealand, Netherlands, Russian Federation, Hungary, Czechia
Sierra Oncology, Inc.

Terminated

Safety and Efficacy of Momelotinib in Subjects With Polycythemia Vera or Essential Thrombocythemia

Polycythemia Vera | Essential Thrombocythemia

United States, France, Germany, Canada, Australia
Daniel Doberer

Terminated

Safety and Efficacy Study of Bosentan in Progressive Pulmonary Sarcoidosis (BOPSAC)

Pulmonary Hypertension | Sarcoidosis

Austria
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Ruxolitinib in the Treatment of Anemic Myelofibrosis Patients. (REALISE)

Primary Myelofibrosis | Post-Essential Thrombocythemia Myelofibrosis | Post-Polycythemia Vera-Myelofibrosis

Belgium, Italy, Spain, Bulgaria, Turkey, Greece, Russian Federation, Austria, Canada, Japan, Germany
Medical University of Vienna

Completed

Effect of Pioglitazone on Portal and Systemic Hemodynamics in Patients With Advanced Cirrhosis

Cirrhosis | Ascites | Portal Hypertension

Austria
University Medicine Greifswald

Unknown

LenusPro Safety (LPS) Study in Patients With PH

Pulmonary Hypertension

Austria, Germany, Netherlands
Keros Therapeutics, Inc.

Recruiting

A Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (PAH) (TROPOS Study).

Pulmonary Arterial Hypertension

United States, Australia
Medical University of Vienna

Completed

Sleep-Disordered Breathing in Chronic Thromboembolic Pulmonary Hypertension

Sleep Disordered Breathing | Chronic Thromboembolic Pulmonary Hypertension

Austria
Medical University of Vienna

Recruiting

Effects of Change in Blood Pressure on Retinal Capillary Rarefaction in Patients With Arterial Hypertension

Arterial Hypertension | Blood Pressure, High

Austria
King Edward Memorial Hospital
The University of Western Australia

Unknown

Prevention of Pre-Term Birth by Treatment of Periodontal Disease

Periodontal Diseases | Premature Birth | Pre-Eclampsia

Australia
Medical University of Vienna

Completed

Effect of Xalacom® (Latanoprost/Timolol) and Combigan® (Brimonidine/Timolol) Fixed Combination on Intraocular Pressure and Ocular Blood Flow in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

Ocular Physiology | Retina

Austria
VividWhite Pty Ltd

Recruiting

VividWhite Glaucoma Implant (VW-51) Pivotal Study

Glaucoma

Australia
Constellation Pharmaceuticals

Active, not recruiting

Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2) (MANIFEST-2)

Primary Myelofibrosis | Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia Myelofibrosis

Korea, Republic of, Spain, United States, Canada, Taiwan, Czechia, United Kingdom, Australia, Italy, Belgium, Germany, France, Israel, Greece, Malaysia, Netherlands, Austria, Turkey, Poland, Thailand, Hong Kong, Hungary
Biosense Webster, Inc.

Completed

RENABLATE Feasibility Study CS156 (EC12-02) Study of Catheter Based Renal Denervation to Treat Resistant Hypertension

Hypertension, Renal

Belgium, Czech Republic, Italy, Australia, Denmark
PolyActiva Pty Ltd

Completed

Safety and Tolerability of a Prostaglandin Ocular Implant for Treatment of Open Angle Glaucoma

Open-angle Glaucoma

Australia
Bayer

Completed

Comparative PK PD Study in PAH Patients (Fox vs. I-Neb)

Pulmonary Arterial Hypertension

Germany, Austria
Medical University of Graz

Completed

Styrian Vitamin D Hypertension Trial

Vitamin D Deficiency | Arterial Hypertension

Austria
Syneos Health

Recruiting

First-in-Human Study of VB0004 in Healthy Subjects and to Patients With Mild to Moderate Hypertension With Low Cardiovascular Risk

Hypertension

Australia
Alcon Research

Completed

A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma

Ocular Hypertension | Glaucoma, Angle-Closure

United States, Australia
Medical University of Graz
Institut National de la Santé Et de la Recherche Médicale, France; University... and other collaborators

Recruiting

Spermidine Anti-Hypertension Study (SMARTEST)

Hypertension

Austria
Medical University of Vienna

Completed

Ocular Hemodynamic Effects of Nitrovasodilators in Healthy Subjects

Glaucoma

Austria
Vienna Hospital Association

Recruiting

Correlation of Structure and Function in Glaucoma

Glaucoma

Austria
Medical University of Vienna

Completed

Optical Angiography in Glaucoma

Glaucoma

Austria
Kona Medical Inc.

Completed

Feasibility Study to Evaluate Renal Denervation Using Focused Ultrasound

Hypertension

Canada, Australia, Czech Republic
Novartis Pharmaceuticals

Terminated

Extension to CQTI571A2102 to Evaluate Long-term Safety, Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension (PAH)

Pulmonary Arterial Hypertension

Germany, Belgium, United Kingdom, United States, Lithuania, Italy, Australia
Massachusetts General Hospital
Sir Charles Gairdner Hospital

Completed

Midodrine for the Treatment of Refractory Hypotension

Critical Illness | Hypotension

United States, Australia
University of Zurich

Completed

Smoking: a Risk Factor for Pulmonary Arterial Hypertension? (DACH)

Pulmonary Hypertension

Switzerland, Germany, Austria
Medical University of Graz

Recruiting

Evaluation of Minimal Invasive Glaucoma Surgery

Glaucoma

Austria
Medical University of Vienna

Completed

Blood Flow Regulation in Glaucoma

Glaucoma

Austria
Wilhelminenspital Vienna
Association for the Promotion of Research in Atherosclerosis, Thrombosis... and other collaborators

Completed

Lowering Blood Pressure in Primary Care in Vienna (Low BP Vienna)

Hypertension

Austria
Royal Brisbane and Women's Hospital

Completed

Efficacy of Therapeutic Interventions for Orthostatic Hypotension in Parkinson's Disease and Multiple System Atrophy

Parkinson's Disease | Multiple System Atrophy | Orthostatic Hypotension

Australia
Medical University of Vienna

Completed

Pharmacodynamic Effects of Riociguat in Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction (DYNAMIC)

Hypertension, Pulmonary | Heart Failure With Normal Ejection Fraction

Austria
Actelion

Completed

Efficacy and Safety of Oral Bosentan in Pulmonary Arterial Hypertension Class II

Pulmonary Hypertension

United States, Netherlands, Canada, Spain, China, Belgium, Germany, Italy, United Kingdom, Switzerland, Australia, Austria, Czech Republic, France
Medical University of Vienna

Recruiting

Vienna Vascular Liver Disease Study (VALID)

Portal Vein Thrombosis | Budd-Chiari Syndrome | Non-Cirrhotic Portal Hypertension | Vascular Liver Disease | Rendu Osler Weber | Cardiac Cirrhosis | Porto-sinusoidal Vascular Disorder

Austria
Invex Therapeutics Ltd.
Premier Research Group plc; University Hospitals Birmingham Neuro Ophthalmology... and other collaborators

Terminated

A Trial to Determine the Efficacy and Safety of Presendin in IIH (IIH EVOLVE)

Idiopathic Intracranial Hypertension

Israel, Germany, Australia, United States, United Kingdom, New Zealand
Medical University of Vienna

Terminated

Assessment of Optic Nerve Radiation in Patients With Glaucoma and Ocular Hypertension by 7 Tesla Diffusion Tensor Imaging

Primary Open Angle Glaucoma | Ocular Hypertension | Normal Tension Glaucoma

Austria
Medical University of Graz

Completed

Effects of a Structured Education Program on Blood Pressure in Essential Hypertensive Patients (herzleben)

Hypertension

Austria
CTI BioPharma
PSI CRO

Recruiting

A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis (PACIFICA)

Primary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia Myelofibrosis

Korea, Republic of, Spain, Canada, Czechia, United States, Australia, France, Hungary, United Kingdom, Romania, Belarus, Bulgaria, Georgia, Germany, Israel, Italy, Poland, Russian Federation, Serbia, Ukraine, Bosnia and Herzegovina and more
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study Comparing The Efficacy, Safety And Tolerability Of Latanoprost 75, 100 And 125 ug/ml To Xalatan In The Treatment Of Primary Open-Angle Glaucoma And Ocular Hypertension

Primary Open Angle Glaucoma | Ocular Hypertension

United Kingdom, France, Australia, Thailand, Portugal, Pakistan, Czechia, Greece
Celgene
Impact Biomedicines, Inc., a wholly owned subsidiary of Celgene Corporation

Active, not recruiting

An Efficacy and Safety Study of Fedratinib Compared to Best Available Therapy in Subjects With DIPSS-intermediate or High-risk Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, or Post-essential Thrombocythemia Myelofibrosis and Previously Treated With Ruxolitinib (FREEDOM2)

Primary Myelofibrosis | Myelofibrosis | Post-Polycythemia Vera

Australia, Austria, Belgium, China, Czechia, France, Germany, Hungary, Italy, Korea, Republic of, Netherlands, Poland, Russian Federation, Spain, Ireland, United Kingdom
CTI BioPharma

Terminated

Pacritinib Versus Best Available Therapy to Treat Myelofibrosis

Primary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia Myelofibrosis

United States, Australia, Belgium, Czechia, France, Germany, Hungary, Italy, Netherlands, New Zealand, Russian Federation, United Kingdom

Clinical Trials on Hypertension,Essential in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations